3篇
您的检索式：作者名="Anil Paramesh"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Kidney Transplantation Alone in ESRD Patients With Hepatitis C Cirrhosis显示文摘 | Anil S. Paramesh John Y. Davis Chaitanya Mallikarjun Rubin Zhang Robert Cannon Nathan Shores Mary T. Killackey Jennifer McGee Bob H. Saggi Douglas P. Slakey Luis Balart Joseph F. Buell | 2012 | Transplantation Journal2012，，3： | 1 |
| 2 | Long-term outcome of ketoconazole and tacrolimus coadministration in kidney transplant patients显示文摘AIM:To study the long-term outcome of ketoconazole and tacrolimus combination in kidney transplant recipients.METHODS:From 2006 to 2010,ketoconazole was given in 199 patients and was continued for at least 1year or until graft failure(Group 1),while 149 patients did not receive any ketoconazole(Group 2).A combination of tacrolimus,mycophenolate and steroid was used as maintenance therapy.High risk patients received basiliximab induction.RESULTS:Basic demographic data was similar between the 2 groups.The 5-year cumulative incidence of biopsy-confirmed and clinically-treated acute rejection was significantly higher in Group 1 than in Group 2(34%vs 18%,P=0.01).The 5-year Kaplan-Meier estimated graft survival(74.3%vs 76.4%,P=0.58)and patient survival(87.8%vs 87.5%,P=0.93)were not differentbetween the 2 groups.Multivariable analyses identified ketoconazole usage as an independent risk of acute rejection(HR=2.33,95%CI:1.33-4.07;P=0.003)while tacrolimus dose in the 2nd month was protective(HR=0.89,95%CI:0.75-0.96;P=0.041).CONCLUSION:Co-administration of ketoconazole and tacrolimus is associated with significantly higher incidence of acute rejection in kidney transplant recipients. | Enver Khan Mary Killackey Damodar Kumbala Heather LaGuardia Yong-Jun Liu Huai-Zhen Qin Brent Alper Anil Paramesh Joseph Buell Rubin Zhang | 2014 | World Journal of Nephrology2014，3，3： | 1 |
| 3 | Deceased donor organ procurement injuries in the United States显示文摘AIM: To determine the incidence of surgical injury during deceased donor organ procurements. METHODS: Organ damage was classified into three tiers, from 1-3, with the latter rendering the organ nontransplantable. For 12 consecutive months starting in January of 2014, 36 of 58 organ procurement organization's(OPO)'s prospectively submitted quality data regarding organ damage(as reported by the transplanting surgeon and confirmed by the OPO medical director) seen on the procured organ.RESULTS: These 36 OPOs recovered 5401 of the nations' s 8504 deceased donors for calendar year 2014.A total of 19043 organs procured were prospectively analyzed. Of this total, 59 organs sustained damage making them non-transplantable(0 intestines; 4 pancreata; 5 lungs; 6 livers; 43 kidneys). The class 3 damage was spread over 22(of 36) reporting OPO's.CONCLUSION: While damage to the procured organ is rare with organ loss being approximately 0.3% of procured organs, loss of potential transplantable organs does occur during procurement. | Tim E Taber Nikole A Neidlinger Muhammad A Mujtaba Elling E Eidbo Roxane L Cauwels Elizabeth M Hannan Jennifer R Miller Anil S Paramesh | 2016 | World Journal of Transplantation2016，6，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员